Aziyo Biologics Inc.

NASDAQ: AZYO · Real-Time Price · USD
1.49
0.03 (2.05%)
At close: Sep 06, 2023, 9:59 PM

Aziyo Biologics Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2022
Cardiovascular Revenue 2.92M 7.28M
Cardiovascular Revenue Growth -59.97% n/a
Women's Health Revenue 11.55M 7.47M
Women's Health Revenue Growth +54.58% n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019
Selling, General, and Administrative Revenue 6.9M 8.99M 7.51M 8.02M 5.56M 7.62M 9.04M 8.46M 9.4M 10.46M 8.93M 7.78M 8.38M 8.33M 8.31M 8.71M 7.37M 6.14M 7.09M 7.44M 6.88M
Selling, General, and Administrative Revenue Growth -23.21% +19.68% -6.35% +44.25% -27.08% -15.63% +6.80% -10.02% -10.14% +17.15% +14.85% -7.16% +0.58% +0.24% -4.64% +18.22% +20.04% -13.39% -4.78% +8.15% n/a
Research and Development Revenue 905K 254K 778K 1M 557K 1.17M 1.8M 2.08M 1.97M 2.62M 2.27M 3.38M 2.29M 1.88M 1.72M 1.27M 863K 1.41M 1.31M 658K 507K
Research and Development Revenue Growth +256.30% -67.35% -22.28% +79.71% -52.43% -35.05% -13.53% +6.05% -24.88% +15.18% -32.70% +47.49% +21.69% +9.36% +35.22% +47.39% -38.71% +7.56% +98.94% +29.78% n/a
Sales and Marketing Revenue 3.03M 770K 2.99M 3.33M 2.8M 3.62M 5.36M 5.06M 4.92M 5.41M 4.82M 4.54M 4.78M 4.8M 4.7M 4.37M 4.17M 4.06M 4.48M 4.57M 4.43M
Sales and Marketing Revenue Growth +293.64% -74.24% -10.24% +18.84% -22.55% -32.45% +5.93% +2.87% -9.08% +12.20% +6.12% -5.08% -0.33% +2.04% +7.52% +4.79% +2.76% -9.37% -1.90% +3.02% n/a